Zobrazeno 1 - 7
of 7
pro vyhledávání: '"William Barbanera"'
Autor:
Alice Chu Jiang, Lela Buckingham, William Barbanera, Amoah Yeboah Korang, Faraz Bishehsari, Joshua Melson
Publikováno v:
Clinical Epigenetics, Vol 9, Iss 1, Pp 1-1 (2017)
Externí odkaz:
https://doaj.org/article/4b7acd78cb514a3fba89be7a583dacbb
Autor:
Tracey Colpitts, Ying Zhang, Kelly A. Kaiser-Walters, William Barbanera, Ping Liu, Jing Du, Lela Buckingham, Ekaterina Pestova
Publikováno v:
Journal of Clinical Oncology. 33:102-102
102 Background: ERG rearrangements are present in about 50% of all prostatic adenocarcinomas (CaP). Using ERG break-apart fluorescence in situ hybridization (FISH) probes, several classes of ERG rearrangement patterns have been described: Edel, Espli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4ae6c683f63a44a79ce80b0a0d2d55a0
https://doi.org/10.1200/jco.2015.33.7_suppl.102
https://doi.org/10.1200/jco.2015.33.7_suppl.102
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 90:S76
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d524911c51357d7f999b92fd7130ce17
https://doi.org/10.1016/j.ijrobp.2014.08.317
https://doi.org/10.1016/j.ijrobp.2014.08.317
Publikováno v:
Journal of Clinical Oncology. 32:e22068-e22068
e22068 Background: Little information about biological indicators of tumor metabolism associated with non small cell lung cancer (NSCLC) in younger patients (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9226618aa982c1a891ccae1a1d471c6c
https://doi.org/10.1200/jco.2014.32.15_suppl.e22068
https://doi.org/10.1200/jco.2014.32.15_suppl.e22068
Autor:
Jing Du, Lela Buckingham, Kelly Kaiser Walters, Ekaterina Pestova, William Barbanera, Thomas A. Hensing, Philip Bonomi, Ying Zhang, Mary J. Fidler
Publikováno v:
Journal of Clinical Oncology. 32:e22043-e22043
e22043 Background: Loss of PTEN and gain of PIK3CA have been postulated as downstream mechanisms of resistance to anti-EGFR therapy in NSCLC. Clinical data suggests use of EGFR tyroisine kinase inh...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::332c9f6f64c948012a983c0b98af0c61
https://doi.org/10.1200/jco.2014.32.15_suppl.e22043
https://doi.org/10.1200/jco.2014.32.15_suppl.e22043
Autor:
Ihab Lamzabi, Richa Jain, Paolo Gattuso, Lela Buckingham, William Barbanera, Shriram Jakate, Rohit I. Singh
Publikováno v:
American Journal of Clinical Pathology. 140:A105-A105
Gastrointestinal (GI) and pancreatic neuroendocrine tumors/carcinomas (NET/C) are a heterogeneous group of tumors, behaving differently depending upon their site of origin. Loss of the cell adhesion factor, E-cadherin (E-cadh), characterizes the tran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::98fca4a9d7c3309c4ace57142731056a
https://doi.org/10.1093/ajcp/140.suppl1.105
https://doi.org/10.1093/ajcp/140.suppl1.105
Autor:
Faraz Bishesari, Lela Buckingham, Alice Chu Jiang, Joshua Melson, William Barbanera, Amoah Yeboah Korang
Publikováno v:
Clinical Epigenetics
Background Conventional tubular adenomas are frequently detected in patients undergoing average risk screening colonoscopy and are over-represented in patients who will develop colorectal cancer (CRC). Whether features of adenomas could serve as pred
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2c22918826d203070fbe8d6c5a0ef52